Medication info
Risene Plus Tablet

Risene Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Allico Pharmaceutical Co., Ltd.
Appearance
Pale orange oval film-coated tablet
Packaging
4 tablets (4 tablets/PTP packaging x 1)
Approval status
Active

MFDS item code 201604686 · Approved 2016.07.29 · Insurance code 656004260

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 1 tablet of this medicine orally once weekly 2. Older adults: No dose adjustment is necessary in older adults (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after food or beverages. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170∼230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. This medicine should not be chewed or sucked because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400IU to 800IU. Taking this medicine once weekly provides one week's supply of vitamin D at a daily dose of 800IU. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
3. Children: Safety and efficacy have not been established in children and growing adolescents.

Ingredients

Manufacturer
Allico Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

View approved original text

This medication is used to treat and prevent osteoporosis in postmenopausal women and men.

How to take

Adult dose

1. Adults: Administer 1 tablet of this medicine orally once weekly 2. Older adults: No dose adjustment is necessary in older adults (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after food or beverages. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170∼230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. This medicine should not be chewed or sucked because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400IU to 800IU. Taking this medicine once weekly provides one week's supply of vitamin D at a daily dose of 800IU. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children: Safety and efficacy have not been established in children and growing adolescents.

Precautions

This medication may irritate the gastrointestinal mucosa, potentially leading to issues such as esophagitis or esophageal ulcers. It should be taken with sufficient water after administration and the patient must remain upright for at least 30 minutes afterward. If symptoms such as dysphagia or heartburn occur, discontinue use immediately and consult a physician. Patients with gastroesophageal reflux diseases, gastritis, or duodenitis should exercise particular caution. Patients with esophageal strictures, severe renal impairment, or particular genetic metabolic disorders should not take this medication. Adequate intake of calcium or vitamin D is required, and calcium supplementation may be necessary. Medications or foods containing calcium, magnesium, or iron should be spaced apart from this medication to avoid interference with absorption. Rare side effects such as osteonecrosis of the jaw may occur, necessitating good oral hygiene, and dental treatment should be discussed with a physician beforehand. If pregnant or breastfeeding, one must consult a physician before deciding to take this medication. Safety in children has not been established, and elderly patients should adhere to general precautions. In cases of overdose, symptoms of hypocalcemia may appear, warranting immediate medical attention. This medication should be kept out of reach of children and not transferred to another container.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • hemorrhage
  • dysphagia
  • odynophagia
  • retrosternal pain
  • heartburn
Show 126 more
  • infection
  • low back pain
  • pain
  • abdominal pain
  • neck pain
  • weakness
  • chest pain
  • neoplasm
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal diseases
  • rectal diseases
  • dental diseases
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension hyperreactivity
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • pruritus
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • duodenitis
  • glossitis
  • abnormal results of liver function tests
  • hypocalcemia
  • hypophosphatemia
  • esophageal stricture
  • achalasia
  • hypocalcemia
  • galactose intolerance
  • Lapp lactase deficiency
  • glucose-galactose malabsorption
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • skin hypersensitivity reaction
  • jaw necrosis
  • liver function impairment
  • jaundice
  • external auditory canal osteonecrosis
  • loss of appetite
  • myalgia
  • asthenia
  • chest burning
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • increased serum alkaline phosphatase
  • facial edema
  • hair loss
  • abnormal olfaction
  • injury due to accident
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • xerostomia
  • peripheral edema
  • traumatic fracture
  • myalgia
  • arthritis
  • low back pain
  • osteoarthritis
  • limb pain
  • muscle stiffness
  • cervical pain
  • asthenia
  • fever
  • falling
  • dizziness
  • bronchitis
  • sinusitis
  • increased cough
  • neuropsychiatric adverse reactions
  • hypercholesterolemia
  • uveitis
  • scleritis
  • iritis
  • hypocalcemia
  • atypical fractures
  • atypical femoral fractures

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it should be kept at room temperature, ideally between 1°C and 30°C, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

Pale orange oval film-coated tablet

Package unit

4 tablets (4 tablets/PTP packaging x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.